glp 1 and ckd

glp 1 and ckd Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation Study uncovers how chronic kidney

Name: glp 1 and ckd Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation Study uncovers how chronic kidney
Brand: actil.am
SKU: 63725221841
Price: 27.74 USD
Availability: InStock
Rating: 4.5985000000000005 (10 reviews)

SKU: 63725221841

4.6

USD27.74 USD62.74

Pay in 4 interest-free payments of $6.93 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 30 - Sep 4

Description

PI3K/Akt/mTOR and MAPK/ERK Pathway Activation In research settings, IGF-1 LR3 activates the PI3K/Akt pathway (involved in survival, glucose metabolism, and protein synthesis), the RAS/MAPK pathway (regulating growth and differentiation), the mTOR pathway (governing anabolic protein synthesis signalling), and IRS-1/2 cross-talk with insulin receptor signalling the full complement of IGF-1R-mediated downstream effects